Dapirolizumab (Anti-TNFSF5 / CD40L / CD154)
Dapirolizumab (Anti-TNFSF5 / CD40L / CD154) (A2313-GRP)
Products
Description
Dapirolizumab (Anti-TNFSF5 / CD40L / CD154) is a humanized immunoglobulin monoclonal antibody that targets TNFSF5. MW : 150 kDa.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2313 |
| Target | CD markers |